Aflac (NYSE:AFL) Price Target Increased to $122.00 by Analysts at Piper Sandler

Aflac (NYSE:AFLFree Report) had its target price hoisted by Piper Sandler from $114.00 to $122.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have an overweight rating on the financial services provider’s stock.

A number of other research analysts also recently issued reports on the stock. UBS Group boosted their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a neutral rating in a research report on Wednesday, August 14th. Jefferies Financial Group dropped their target price on shares of Aflac from $84.00 to $83.00 and set a hold rating on the stock in a research report on Friday, June 28th. Evercore ISI boosted their target price on shares of Aflac from $84.00 to $90.00 and gave the company an underperform rating in a research report on Thursday, September 26th. Wells Fargo & Company boosted their target price on shares of Aflac from $81.00 to $90.00 and gave the company an equal weight rating in a research report on Monday, August 12th. Finally, Morgan Stanley boosted their target price on shares of Aflac from $91.00 to $98.00 and gave the company an equal weight rating in a research report on Monday, August 19th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of Hold and an average price target of $95.43.

Get Our Latest Stock Report on Aflac

Aflac Trading Up 1.5 %

AFL opened at $115.27 on Wednesday. The firm has a market capitalization of $65.50 billion, a price-to-earnings ratio of 12.72, a PEG ratio of 2.60 and a beta of 0.95. Aflac has a fifty-two week low of $75.07 and a fifty-two week high of $115.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.10. The company’s 50 day moving average price is $106.42 and its two-hundred day moving average price is $93.88.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The company’s revenue for the quarter was down .7% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.58 EPS. As a group, research analysts predict that Aflac will post 6.75 earnings per share for the current year.

Aflac Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were issued a dividend of $0.50 per share. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 annualized dividend and a yield of 1.74%. Aflac’s payout ratio is 22.08%.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Aflac

Institutional investors have recently made changes to their positions in the company. Y.D. More Investments Ltd bought a new stake in shares of Aflac in the 2nd quarter worth $25,000. Atwood & Palmer Inc. grew its position in Aflac by 80.0% during the first quarter. Atwood & Palmer Inc. now owns 315 shares of the financial services provider’s stock valued at $27,000 after buying an additional 140 shares during the period. OFI Invest Asset Management bought a new position in Aflac during the first quarter valued at about $29,000. Dixon Mitchell Investment Counsel Inc. bought a new position in Aflac during the first quarter valued at about $34,000. Finally, Cedar Wealth Management LLC bought a new position in Aflac during the first quarter valued at about $50,000. Institutional investors own 67.44% of the company’s stock.

Aflac Company Profile

(Get Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Articles

Analyst Recommendations for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.